The UK’s first dedicated synthetic biology company with a world leading platform of technologies for the rapid engineering and optimisation of novel biological production systems. A spin out of University College London, Synthace is already producing high-value research and development products for the pharmaceutical, agrochemical and fine chemicals industry. Synthace bioengineering is enabled by a tight integration of computational modelling and big data analysis with wet lab experimental design and validation, and novel molecular biology tools. While Synthace bioengineering is broadly applicable across multiple industry sectors, the company is focused towards applications in the production of specialty chemicals.
Company Growth (employees)
London, GB
Size (employees)
29 (est)+4%
Synthace was founded in 2011 and is headquartered in London, GB

Key People at Synthace

Tim Fell

Tim Fell

Christopher Grant Ward

Christopher Grant Ward

Markus Gershater

Markus Gershater

Sean Ward

Sean Ward

Founder and CTO

Synthace Office Locations

Synthace has an office in London
London, GB (HQ)
2 Royal College St

Synthace Data and Metrics

Summary Metrics

Founding Date


Total Funding

$2.9 m

Latest funding size

$1.9 m

Time since last funding

almost 4 years


Synthace's latest funding round in September 2013 was reported to be $1.9 m. In total, Synthace has raised $2.9 m

Synthace Financial Metrics


Cash (31-May-2016)

245 k
GBPFY, 2014FY, 2015FY, 2016


321.7 k1.5 m245 k

Accounts Receivable

159.9 k73.2 k401.8 k

Current Assets

481.6 k1.6 m646.8 k


298.8 k200.5 k265.6 k

Total Assets

780.4 k1.8 m912.3 k

Accounts Payable

183.5 k103 k154.8 k

Current Liabilities

183.5 k103 k154.8 k

Total Liabilities

183.5 k103 k154.8 k

Total Equity

596.9 k1.7 m757.5 k

Financial Leverage

1.3 x1.1 x1.2 x
Y, 2016

Financial Leverage

1.2 x

Synthace Online and Social Media Presence

Synthace Company Life and Culture

You may also be interested in